Germany statutory health insurance expenditure, quarterly
Germany statutory health insurance expenditure, quarterly stood at 93,201.03 EUR million in Q1 2026, according to Deutsche Bundesbank. It is one of the indicators in the Government finances (quarterly) table (Value · Quarterly), with a complete series running from Q1 2000 to Q1 2026. The complete series with an interactive chart, free to download.
This indicator in the Government finances (quarterly) table
| Indicator | Q1-2026 | Q4-2025 | Q3-2025 | Q2-2025 | Q1-2025 | Q4-2024 | Q3-2024 | Q2-2024 | Q1-2024 | Q4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scheme, expenditure, total7 | 93,201.03 | 90,638.41 | 88,016.97 | 87,514.58 | 86,490.03 | 84,126.56 | 81,579.28 | 82,224.16 | 80,253.23 | 78,859.89 | |
| Scheme, expenditure, administrative expenditure | 3,244.98 | 3,589.36 | 3,168.96 | 3,341.01 | 3,247.19 | 3,290.02 | 3,195.13 | 3,190.43 | 3,069.46 | 3,452.12 | |
| Scheme, expenditure, sickness benefits | 5,905.46 | 5,418.91 | 5,365.41 | 5,315.7 | 5,531.54 | 5,146.83 | 5,133.21 | 5,117.75 | 5,147.82 | 4,808.67 |
Understanding germany statutory health insurance expenditure, quarterly
Total outlays by the statutory health insurance scheme capture all medical, operational, and administrative costs incurred by the public coverage network. Unlike specific treatment lines further down the ledger, this aggregate accounts for the entire spectrum of funded services, ranging from outpatient consultations and prescription pharmaceuticals to statutory sick pay and the bureaucratic overhead of managing the funds themselves. It maps the complete financial outflow of the mandatory medical coverage system across the country, capturing the gross liabilities before any offsets from patient co-payments or rebates are applied to the ledger.
Analyzing these expenditure figures requires adjusting for seasonal morbidity patterns, particularly the elevated respiratory illness rates that consistently concentrate costs in the early months of the calendar. Year-on-year evaluations offer the most rigorous method to track structural shifts in medical pricing and demographic burdens, bypassing these short-term cyclical health events. Routine statistical revisions frequently occur as delayed quarterly billing from regional physician associations slowly filters into the finalized accounting framework. Analysts must separate this specific measure from broader public health spending, as the statutory insurance network operates through payroll contributions and remains distinct from direct federal budget disbursements or private medical coverage.
Frequently asked questions
- Does this total include administrative costs of the insurance funds?
- Yes, the aggregate outlays cover the bureaucratic overhead required to run the statutory funds alongside direct medical expenditures.
- Are private health insurance payouts captured in this series?
- No, the series strictly isolates the mandatory statutory network and excludes entirely the disbursements from private medical insurers.
- How do patient co-payments affect these expenditure figures?
- The data reflects the gross costs incurred by the statutory funds, meaning patient co-payments are not deducted from these recorded outlays.